These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 2615197

  • 1. Long-term effects of calcium carbonate and 2.5 mEq/liter calcium dialysate on mineral metabolism.
    Slatopolsky E, Weerts C, Norwood K, Giles K, Fryer P, Finch J, Windus D, Delmez J.
    Kidney Int; 1989 Nov; 36(5):897-903. PubMed ID: 2615197
    [Abstract] [Full Text] [Related]

  • 2. Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group.
    Weinreich T, Passlick-Deetjen J, Ritz E.
    Am J Kidney Dis; 1995 Mar; 25(3):452-60. PubMed ID: 7872324
    [Abstract] [Full Text] [Related]

  • 3. Calcium carbonate is an effective phosphate binder when dialysate calcium concentration is adjusted to control hypercalcemia.
    Mactier RA, Van Stone J, Cox A, Van Stone M, Twardowski Z.
    Clin Nephrol; 1987 Nov; 28(5):222-6. PubMed ID: 3427832
    [Abstract] [Full Text] [Related]

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 5. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group.
    Weinreich T, Ritz E, Passlick-Deetjen J.
    Perit Dial Int; 1996 Nov; 16(3):260-8. PubMed ID: 8761540
    [Abstract] [Full Text] [Related]

  • 6. The effects of calcium carbonate as the sole phosphate binder in combination with low calcium dialysate and calcitriol therapy in chronic hemodialysis patients.
    Oettinger CW, Oliver JC, Macon EJ.
    J Am Soc Nephrol; 1992 Oct; 3(4):995-1001. PubMed ID: 1450373
    [Abstract] [Full Text] [Related]

  • 7. Use of calcium carbonate as a phosphate binder in dialysis patients.
    Hercz G, Kraut JA, Andress DA, Howard N, Roberts C, Shinaberger JH, Sherrard DJ, Coburn JW.
    Miner Electrolyte Metab; 1986 Oct; 12(5-6):314-9. PubMed ID: 3807829
    [Abstract] [Full Text] [Related]

  • 8. Calcium carbonate as a phosphate binder: is there a need to adjust peritoneal dialysate calcium concentrations for patients using CaCO3?
    Martis L, Serkes KD, Nolph KD.
    Perit Dial Int; 1989 Oct; 9(4):325-8. PubMed ID: 2488389
    [Abstract] [Full Text] [Related]

  • 9. Alternative phosphate binders in dialysis patients: calcium carbonate.
    Slatopolsky E, Weerts C, Stokes T, Windus D, Delmez J.
    Semin Nephrol; 1986 Dec; 6(4 Suppl 1):35-41. PubMed ID: 3602677
    [Abstract] [Full Text] [Related]

  • 10. The requirement of low calcium dialysate in patients on continuous ambulatory peritoneal dialysis receiving calcium carbonate as a phosphate binder.
    Cheng IK, Lu HB, Chan CY, Cheng SW, Robinson JD, Tam SC, Lo WK, Cheung WC.
    Clin Nephrol; 1993 Aug; 40(2):100-5. PubMed ID: 8222365
    [Abstract] [Full Text] [Related]

  • 11. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
    Janssen MJ, van der Kuy A, ter Wee PM, van Boven WP.
    Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of long-term treatment with calcium carbonate as a phosphate binder.
    Malberti F, Surian M, Poggio F, Minoia C, Salvadeo A.
    Am J Kidney Dis; 1988 Dec; 12(6):487-91. PubMed ID: 3143260
    [Abstract] [Full Text] [Related]

  • 13. Improvement of severe secondary hyperparathyroidism in dialysis patients by intravenous 1 alpha(OH) vitamin D3, oral CaCO3 and low dialysate calcium.
    Moriniere P, el Esper N, Viron B, Judith D, Bourgeon B, Farquet C, Gheerbrant J, Chapuy M, Van Orshoven A, Pamphile R.
    Kidney Int Suppl; 1993 Jun; 41():S121-4. PubMed ID: 8320904
    [Abstract] [Full Text] [Related]

  • 14. Calcium kinetics and the long-term effects of lowering dialysate calcium concentration.
    Argilés A, Kerr PG, Canaud B, Flavier JL, Mion C.
    Kidney Int; 1993 Mar; 43(3):630-40. PubMed ID: 8455362
    [Abstract] [Full Text] [Related]

  • 15. Long-term CaCO3 treatment of chronic hemodialysis patients: an attempt to prevent aluminum osteopathy.
    Matsubara M, Unagami H, Totsune K, Sato H, Kikuta Y, Ogawa M, Saito T, Yoshinaga K.
    ASAIO Trans; 1988 Mar; 34(3):168-71. PubMed ID: 3196505
    [Abstract] [Full Text] [Related]

  • 16. Low-calcium dialysis fluid and oral calcium carbonate in CAPD. A method of controlling hyperphosphataemia whilst minimizing aluminium exposure and hypercalcaemia.
    Hutchison AJ, Freemont AJ, Boulton HF, Gokal R.
    Nephrol Dial Transplant; 1992 Mar; 7(12):1219-25. PubMed ID: 1337163
    [Abstract] [Full Text] [Related]

  • 17. CAPD with low calcium dialysate and calcium carbonate: results of a 24-week study.
    Honkanen E, Kala AR, Grönhagen-Riska C, Ikäheimo R.
    Adv Perit Dial; 1992 Mar; 8():356-61. PubMed ID: 1361822
    [Abstract] [Full Text] [Related]

  • 18. Calcium carbonate is an effective phosphorus binder in children with chronic renal failure.
    Andreoli SP, Dunson JW, Bergstein JM.
    Am J Kidney Dis; 1987 Mar; 9(3):206-10. PubMed ID: 3826069
    [Abstract] [Full Text] [Related]

  • 19. Sevelamer hydrochloride with or without alphacalcidol or higher dialysate calcium vs calcium carbonate in dialysis patients: an open-label, randomized study.
    Sadek T, Mazouz H, Bahloul H, Oprisiu R, El Esper N, El Esper I, Boitte F, Brazier M, Moriniere P, Fournier A.
    Nephrol Dial Transplant; 2003 Mar; 18(3):582-8. PubMed ID: 12584283
    [Abstract] [Full Text] [Related]

  • 20. The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.
    Van Buren PN, Lewis JB, Dwyer JP, Greene T, Middleton J, Sika M, Umanath K, Abraham JD, Arfeen SS, Bowline IG, Chernin G, Fadem SZ, Goral S, Koury M, Sinsakul MV, Weiner DE, Collaborative Study Group.
    Am J Kidney Dis; 2015 Sep; 66(3):479-88. PubMed ID: 25958079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.